NR4A1 and breast carcinoma: It has been reported that the characteristics of MBC are similar to those of postmenopausal female breast cancer [3], but there are also reports that hormonal receptor studies and studies of the therapeutic efficacy of aromatase inhibitors indicate MBC to differ from female breast cancer [12-15].